Related Experiment Videos
Doxepin as an adjunct in the treatment of chronic pain
The Journal of Clinical Psychiatry
|August 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Evaluation and management of back pain: preventing disability.
Journal of back and musculoskeletal rehabilitation·2014
Commentary: the potential for unintended consequences from public policy shifts in the treatment of pain.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2000
Management of chronic pain and control of long-term disability.
Occupational medicine (Philadelphia, Pa.)·2000
Opioids in chronic pain management: is there a significant risk of addiction?
Current review of pain·2000
Are pain disorder and somatization disorder valid diagnostic entities?
Current review of pain·2000
Chronic pain and the disability epidemic.
The Clinical journal of pain·1991
GLP-1 Receptor Agonists and Risk of Kidney Replacement Therapy and Health Care Utilization in Bipolar Disorder With Chronic Kidney Disease.
The Journal of clinical psychiatry·2026
Treatment-Resistant Depression as a Dynamic Continuum: A Consensus Panel Report on Mechanism-Informed Pharmacologic Sequencing.
The Journal of clinical psychiatry·2026
Impact of Cannabis Use on Time to Psychiatric Rehospitalization in Young Adults With Bipolar and Psychotic Disorders: A Survival Analysis.
The Journal of clinical psychiatry·2026
The Role of Chronic Anhedonia in the Relationship Between Treatment-Resistant Depression and Suicidality.
The Journal of clinical psychiatry·2026
An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression.
The Journal of clinical psychiatry·2026
Correction. Evaluation of Sexual Function With Adjunctive Lumateperone in Patients With Major Depressive Disorder.
The Journal of clinical psychiatry·2026
Aldosterone synthase inhibitors may alter how primary care treats hypertension.
American journal of hypertension·2026
The hypertension specialist's perspective: aldosterone synthase inhibitors to fill the gap in difficult-to-control and resistant hypertension.
American journal of hypertension·2026
From bench to formulary: a pharmacological appraisal of aldosterone synthase inhibitors for uncontrolled and resistant hypertension.
American journal of hypertension·2026
Lessons from the history of antipsychotic discovery: part 3 - muscarinic mechanisms.
BJPsych bulletin·2026